Showing 281 - 300 results of 1,139 for search '"preclinical"', query time: 0.04s Refine Results
  1. 281
  2. 282

    Bioactive compounds of Calotropis gigantea for cancer treatment by Jayalekshmi C, Nishanth Mohan Das, Rajiv Periakaruppan

    Published 2024-06-01
    “…These challenges include optimizing drug delivery systems, conducting comprehensive preclinical and clinical studies, and ensuring compliance with regulatory standards. …”
    Get full text
    Article
  3. 283

    Strong concordance between RNA structural and single nucleotide variants identified via next generation sequencing techniques in primary pediatric leukemia and patient-derived xeno... by Sonali P. Barwe, Anilkumar Gopalakrisnapillai, Nitin Mahajan, Todd E. Druley, E. Anders Kolb, Erin L. Crowgey

    Published 2020-03-01
    “…Patient-derived xenograft (PDX) models are increasingly being used for preclinical testing of novel treatment modalities. A novel approach involving targeted error-corrected RNA sequencing using ArcherDX HemeV2 kit was employed to compare 25 primary pediatric acute leukemia samples and their corresponding PDX samples. …”
    Get full text
    Article
  4. 284
  5. 285
  6. 286

    Melanin-like nanoparticles as a potential novel therapeutic approach in ADPKD by Laura Cassina, Alessandra Boletta

    Published 2024-11-01
    “…In this issue of EMBO Molecular Medicine, Sun and colleagues report the development of a novel therapeutic approach, and preclinical proof-of-concept evidence of its efficacy, for Autosomal Dominant Polycystic Kidney Disease (ADPKD) (Sun et al, 2024).…”
    Get full text
    Article
  7. 287
  8. 288
  9. 289

    Think Stop before Going 'Off-Label' by Gerald Y Minuk

    Published 2004-01-01
    “…Only after careful and extensive review of all available safety and efficacy data derived from preclinical and clinical trials will a regulatory body approve the licensing of a drug for a specific medical condition ('indication'). …”
    Get full text
    Article
  10. 290
  11. 291
  12. 292

    Mechanical HIFU and immune checkpoint inhibition: toward clinical implementation by Vera Mekers, Mirjam de Visser, Karijn Suijkerbuijk, Clemens Bos, Chrit Moonen, Roel Deckers, Gosse Adema

    Published 2024-12-01
    “…We report on the effect of M-HIFU on soluble immune modulators and immune cells in different preclinical models, and potential contributions to the anti-tumor immune response. …”
    Get full text
    Article
  13. 293

    Developing a taxonomy to describe offspring outcomes in studies involving pregnant mammals' exposure to non-tobacco nicotine: A systematic scoping review. by Lucy Phillips, Ross Thomson, Tom Coleman-Haynes, Sue Cooper, Felix Naughton, Lisa Mcdaid, Joanne Emery, Tim Coleman

    Published 2023-01-01
    “…<h4>Introduction</h4>Many countries recommend Nicotine Replacement Therapy (NRT) for smoking cessation in pregnancy. Preclinical studies of nicotine exposure to pregnant mammals could indicate how nicotine may adversely affect the developing fetus. …”
    Get full text
    Article
  14. 294

    Experimental approach to obtaining subcutaneous xenograft of non-small cell lung cancer by E. A. Lukbanova, M. V. Mindar, E. A. Dzhenkova, A. Yu. Maksimov, A. S. Goncharova, Yu. S. Shatova, A. A. Maslov, A. V. Shaposhnikov, E. V. Zaikina, Yu. N. Lazutin

    Published 2022-06-01
    “…The created PDX models can be recommended as test systems for preclinical studies of the effectiveness of new pharmacological substances with potential antitumor activity.…”
    Get full text
    Article
  15. 295
  16. 296

    Nanoformulation of Spirooxindole and Methods for Treating Hepatocellular Carcinoma by Assem Barakat, Fardous F. El-Senduny, Mohammad Shahidul Islam, Abdullah Mohammed Al-Majid, Yaseen A. M. M. Elshaier, Eman A. Mazyed, Farid A. Badria

    Published 2025-01-01
    “…<b>Conclusions:</b> This study presents a novel, safe, and effective chemical entity of spirooxindole derivatives for further preclinical and clinical studies.…”
    Get full text
    Article
  17. 297

    New Therapeutic Targets for Mood Disorders by Rodrigo Machado-Vieira, Giacomo Salvadore, Nancy DiazGranados, Lobna Ibrahim, David Latov, Cristina Wheeler-Castillo, Jacqueline Baumann, Ioline D. Henter, Carlos A. Zarate

    Published 2010-01-01
    “…Here we describe a number of targets/compounds that clinical and preclinical studies suggest could result in putative novel treatments for mood disorders. …”
    Get full text
    Article
  18. 298

    Efficacy of vaccines based on chimeric or multiepitope antigens for protection against visceral leishmaniasis: A systematic review. by Karine Ferreira Lopes, Mariana Lourenço Freire, Silvane Maria Fonseca Murta, Edward Oliveira

    Published 2024-12-01
    “…<h4>Conclusions</h4>Vaccine formulations containing various chimeric or multiepitope antigens have been developed and evaluated in different preclinical trials, with only one advancing to clinical trials and commercialization. …”
    Get full text
    Article
  19. 299

    Advances in Stem Cell Therapy for Huntington’s Disease: A Comprehensive Literature Review by Siddharth Shah, Hadeel M. Mansour, Brandon Lucke-Wold

    Published 2025-01-01
    “…There is strong evidence supporting the transplantation of stem cells or their derivatives in HD animal models, even if stem-cell-based preclinical and clinical trials are still in their early stages. …”
    Get full text
    Article
  20. 300

    Combined PARP14 inhibition and PD-1 blockade promotes cytotoxic T cell quiescence and modulates macrophage polarization in relapsed melanoma by Chun Wai Wong, Rotem Leshem, Kieran Neil Sefton, I-Hsuan Lin, Dervla Tamara Isaac, Mario Niepel, Adam Hurlstone

    Published 2025-01-01
    “…PARP14 inhibition prolongs PD-1 blockade responses in preclinical models, but fails to achieve full tumor clearance, suggesting the involvement of additional resistance mechanisms.Methods We identified a robust PARP14 catalytic inhibitor gene signature and evaluated its association with patient survival. …”
    Get full text
    Article